46 -8 (82) 2025 - Hamroeva L.K., Rustamova N.A. - ABNORMAL PLACENTATION: CAUSES, RISKS AND MODERN METHODS OF DIAGNOSIS

ABNORMAL PLACENTATION: CAUSES, RISKS AND MODERN METHODS OF DIAGNOSIS

Hamroeva L.K. - Samarkand State Medical University

Rustamova N.A. - Samarkand State Medical University

Resume

Placenta accreta spectrum (PAS) remains one of the most serious complications in obstetric practice, associated with a high risk of maternal morbidity and mortality. Key aspects of patient management include timely prenatal diagnosis, patient counseling, and thorough delivery planning. Determining the depth of placental invasion is crucial for selecting the optimal management strategy, as it allows prediction of outcomes and minimization of massive hemorrhage and surgical complications. International recommendations (ACOG, SMFM) emphasize the need for these patients to be managed in specialized level III facilities that provide round-the-clock access to a multidisciplinary team of specialists, massive transfusion protocols, and advanced surgical and interventional treatment methods.

Keywords: Placenta accreta spectrum (PAS); prenatal diagnosis; obstetric complications; cesarean section; massive hemorrhage; multidisciplinary approach; management strategy; level III resources; uterine artery embolization.

First page

259

Last page

264

For citation:Hamroeva L.K., Rustamova N.A. - ABNORMAL PLACENTATION: CAUSES, RISKS AND MODERN METHODS OF DIAGNOSIS//New Day in Medicine 8(82)2025 259-264 https://newdayworldmedicine.com/en/new_day_medicine/8-82-2025

List of References

  1. Барановская Е.И. Этиология и диагностика placenta accreta // Российский вестник акушера-гинеколога. – 2020. – Т. 20, № 3. – С. 24–28. https://doi.org/10.17116/rosakush20202003124.
  2. Каримов З. Д., Абдикулов Б. С. К вопросу оптимизации хирургической тактики и кровосберегающих технологий при врастании плаценты в рубец на матке //Журнал им. НВ Склифосовского «Неотложная медицинская помощь». – 2023. – Т. 12. – №. 2. – С. 274-281.;
  3. Лебеденко Е.Ю., Беспалая А.В., Феоктистова Т.Е., Рымашевский М.А. Анализ мировых трендов уровня кесарева сечения с использованием классификации Робсона // Медицинский вестник Юга России. – 2021. – Т. 12, № 2. – С. 16–21. https://doi.org/10.21886/2219-8075-2021-12-2-16-21.
  4. Оленев А.С. Резервы снижения материнской смертности в условияхмегаполиса: дис.… д-ра мед. наук. – Москва, 2022.
  5. Оленев А.С., Новикова В.А., Радзинский В.Е. Мировые концептуальные подходы к снижению материнской смертности // Акушерство и гинекология: Новости. Мнения. Обучения. – 2018. – № Приложение 3 (21). – С. 5–17.
  6. Сюндюкова Е.Г., Чуланова Ю.С., Сашенков С.Л. и др. Предлежание и врастание плаценты: вопросы диагностики и акушерской тактики // Российский вестник акушера-гинеколога. – 2022. – Т. 22, № 3. – С. 12–20. https://doi.org/10.17116/rosakush20222203112.
  7. Anaposala S. et al. Postpartum hemorrhage and tranexamic acid: a literature review //Cureus. – 2023. – Т. 15. – №. 5.;
  8. Betran A.P., Ye J., Moller A.B., Souza J.P., Zhang J. Trends and projections of caesarean section rates: global and regional estimates // BMJ Global Health. – 2021. – Vol. 6, № 6. – e005671. https://doi.org/10.1136/bmjgh-2021-005671.
  9. De Braud L.V., Knez J., Mavrelos D., Thanatsis N., Jauniaux E., Jurkovic D. Risk prediction of major haemorrhage with surgical treatment of live cesarean scar pregnancies. Eur J Obstet Gynecol Reprod Biol. 2021;264:224–231.
  10. Di Spiezio Sardo A., Saccone G., McCurdy R., Bujold E., Bifulco G., Berghella V. Risk of cesarean scar defect following single- vs double-layer uterine closure: systematic review and meta-analysis of randomized controlled trials. Ultrasound Obstet Gynecol. 2017;50:578–583.
  11. Einerson B.D., Gilner J.B., Zuckerwise L.C. Placenta accreta spectrum // Obstetrics & Gynecology. – 2023. – Vol. 142, № 1. – P. 31–50. https://doi.org/10.1097/AOG.0000000000005229.
  12. Familiari A., Liberati M., Lim P., et al. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018;97(5):507–520.
  13. Feldman N., Maymon R., Jauniaux E., et al. Prospective evaluation of the ultrasound signs proposed for the description of uterine niche in nonpregnant women. J Ultrasound Med. 2022;41:917–923.
  14. Jauniaux E., Bhide A., Kennedy A., et al.; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening // Int Gynaecol Obstet. – 2018. – Vol. 140, № 3. – P. 274–280. https://doi.org/10.1002/ijgo.12408.
  15. Jauniaux E. et al. Placenta accreta spectrum // Nature Reviews Disease Primers. – 2025. – Т. 11, № 1. – С. 40
  16. Mielke R. T., Obermeyer S. The use of tranexamic acid to prevent postpartum hemorrhage //Journal of Midwifery & Women's Health. – 2020. – Т. 65. – №. 3. – С. 410-416
  17. Marcellin L. et al. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta // Am J Obstet Gynecol. – 2018.
  18. Mogos M.F., Salemi J.L., Ashley M., et al. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998–2011 // J Matern Fetal Neonatal Med. – 2016. – Vol. 29, № 7. – P. 1077–1082. https://doi.org/10.3109/14767058.2015.1034103.
  19. Nieto-Calvache A.J., Jauniaux E., Fox K.A., et al.; International Society for PAS (IS-PAS) LMIC Working Group. Are international guideline recommendations for the management of placenta accreta spectrum applicable in low- and middle-income countries? // Int J Gynaecol Obstet. – 2024. – Vol. 166, № 3. – P. 1047–1056. https://doi.org/10.1002/ijgo.15473.
  20. Silver R.M., Branch D.W. Placenta accreta spectrum // N Engl J Med. – 2018. – Vol. 378, № 16. – P. 1529–1536. https://doi.org/10.1056/NEJMcp1709324.

    file

    download